TABLE 4.

Helicobacter pylori eradication therapy for chronic renal failure patients

Year	Author	Country	Number	Regimen	Eradication rate	Determine methods	Resistance
1997	Tamura H (70)	Japan	14	LPZ (30) oid/ 8 weeks, AMPC (500) oid/ 3 weeks, plaunotol (80) tid/ 24 weeks	78.6%	RUT, Culture, Histology	No data
1998	Munos de Bustillo E (28)	Spain	23	OPZ (20) bid, AMPC (500) tid/ 14 days	60.8%	UBT	No data
			23	Plus OPZ (20) bid, CAM (500) bid/ 14 days	82.6%
1998	Tokushima H (71)	Japan	17	LPZ (30) oid/ 8 weeks, AMPC (500)/3 weeks	76.5%	RUT, Culture, Histology	No data
			10	LPZ (30) oid, AMPC (250), MNZ (250) bid/ 7 days	90.0%
1999	Araki H (31)	Japan	17	OPZ (20) oid/ 8 weeks, AMPC (250) oid, CAM (200) oid/ 3 weeks, polaprizinc (0.5) bid/ 24 weeks	88.2%	IgG, Histology	No data
1999	Gur G (32)	Turkey	25	FAM (40) oid, CAM (500) bid, MNZ (250) bid/ 15 days	80.0%	Histology, RUT	No data
2001	Wang YL (35)	China	38	OPZ (20), AMPC (1000), CAM (500) bid/ 7 days	86.8%	Stool	No data
2002	Mak SK (72)	China	21 (CRF)	OPZ (20), AMPC (1000), CAM (500) bid/ 7 days	90.5%	RUT	No data
2002	Tsukada K (38)	Japan	39	OPZ (30) bid, AMPC (500) tid, CAM (400) bid/ 7 days	82.1%	UBT	No data
2003	Mak SK (73)	China	25 (CRF)	OPZ (20) or LPZ (30), AMPC (1000), CAM (5O0) bid/ 7 days	96.0%	Histology	No data
2003	Sheu BS (74)	China	38 (CRF)	LPZ (30), AMPC (750), CAM (500) bid/ 7 days	76.3%
			40 (CRF)	LPZ (30), CAM (500), MNZ (500) bid/ 7 days	92.5%	Stool	No data
2004	Sezer S (4)	Turkey	17	OPZ (20), AMPC (1000), CAM (500) bid/ 14 days	94.1%	Endoscopy	No data
2007	Tseng GY (75)	China	34 (CRF)	ESO (40) or OPZ (20) bid, AMPC (1000) bid, CAM (500) bid/ 7 days	94.1%	UBT	No data
2007	Itatsu T (46)	Japan	11	LPZ (60), AMPC (750), CAM (400)/ 7 days	72.7%	RUT	No data
			9	LPZ (60), CAM (400)/ 7 days	33.3%

AMPC, amoxicillin; CAM, clarithromycin; Eso, Esomeprazole; FAM, famotidine; LPZ, lansoprazole; MNZ, metronidazole; OPZ, omeprazole; RUT, rapid urease test; UBT, urea breath test.